Physician profile
Ryan J Kim
NPI 1881905222
$50,232.83
in general payments reported to CMS, 2019-2025
28 companies · $12K in 2025
The $12K reported for 2025 was more than what 92% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,323 · 2020: $2,202 · 2021: $2,071 · 2022: $1,448 · 2023: $13K · 2024: $15K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $26K · Travel and Lodging: $7,062 · Food and Beverage: $5,210 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $26,416.67 |
| Travel and Lodging | $7,062.35 |
| Food and Beverage | $5,210.06 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $26,500.37 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Smart Port Ct |
| W. L. Gore & Associates, INC. | $7,653.43 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis |
| Silk Road Medical, INC. | $6,583.09 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Terumo Medical Corporation | $3,061.94 | 2019-2025 | Azur Cx Detachable, Hydropearl, Navicross |
| Cardiovascular Systems INC. | $2,140.89 | 2019-2023 | Diamondback Peripheral |
| Boston Scientific Corporation | $1,136.37 | 2019-2025 | Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Varithena Administration Pack |
| Abbott Laboratories | $898.57 | 2019-2025 | Diamondback Peripheral, Esprit, Supera |
| Endologix LLC | $405.91 | 2022-2024 | Afx2 Bifurcated Endograft System |
| Cardiva Medical, INC. | $400.14 | 2022-2025 | Cardiva Vascade 6/7f Vcs |
| Philips North America LLC | $340.02 | 2019-2024 | (Bh4) Igt Devices Undivided |
| Medtronic, INC. | $220.72 | 2021-2025 | Venaseal, Valiant Captivia, Heli-Fx Endoanchor System |
| Cordis US Corp. | $136.89 | 2022-2025 | Saber, Mynx Control |
| Smith+Nephew, INC. | $101.53 | 2023-2025 | Stravix, Collagenase Santyl, Grafix |
| Cook Medical LLC | $83.99 | 2019-2025 | Zenith, Icast Covered Stent System, 6mmx22mmx120cm |
| Bard Peripheral Vascular, INC. | $81.01 | 2019-2024 | Venclose Maven Catheter |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $76.74 | 2022-2024 | Xarelto |
| Medtronic Vascular, INC. | $75.21 | 2019-2020 | |
| Teleflex LLC | $68.07 | 2021-2025 | Manta |
| Cardinal Health 200 LLC | $60.24 | 2019 | |
| Bolton Medical INC | $46.70 | 2024 | Treo Abdominal Stent-Graft System |
| Convatec INC. | $38.82 | 2024 | |
| Stryker Corporation | $27.08 | 2020 | |
| Shockwave Medical, INC | $23.40 | 2022 | |
| Ekos Corporation | $19.54 | 2019 | |
| Cardio Flow, INC. | $15.53 | 2025 | |
| Kci USA, INC. | $13.17 | 2023 | Prevena |
| Getinge USA Sales, LLC | $12.34 | 2019 | |
| Pfizer INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.